Explore the Potential with AI-Driven Innovation
The specialised, focused library is developed on demand with the most recent virtual screening and parameter assessment technology, guided by the Receptor.AI drug discovery platform. This approach exceeds the capabilities of traditional methods and offers compounds with higher activity, selectivity, and safety.
The compounds are cherry-picked from the vast virtual chemical space of over 60B molecules. The synthesis and delivery of compounds is facilitated by our partner Reaxense.
The library includes a list of the most promising modulators annotated with 38 ADME-Tox and 32 physicochemical and drug-likeness parameters. Also, each compound is presented with its optimal docking poses, affinity scores, and activity scores, providing a comprehensive overview.
Our high-tech, dedicated method is applied to construct targeted libraries.
Fig. 1. The sreening workflow of Receptor.AI
Our methodology leverages molecular simulations to examine a vast array of proteins, capturing their dynamics in both isolated forms and in complexes with other proteins. Through ensemble virtual screening, we thoroughly account for the protein's conformational mobility, identifying critical binding sites within functional regions and distant allosteric locations. This detailed exploration ensures that we comprehensively assess every possible mechanism of action, with the objective of identifying novel therapeutic targets and lead compounds that span a wide spectrum of biological functions.
Our library is unique due to several crucial aspects:
partner
Reaxense
upacc
P19021
UPID:
AMD_HUMAN
Alternative names:
-
Alternative UPACC:
P19021; A6NMR0; A8K293; O43211; O95080; Q16252; Q16253; Q54A45; Q86U53; Q8WVC7; Q9UCG0
Background:
Peptidyl-glycine alpha-amidating monooxygenase plays a pivotal role in the biosynthesis of bioactive peptides through a two-step post-translational modification. This bifunctional enzyme first hydroxylates the C-terminal glycine of peptidylglycine substrates, followed by cleavage to produce alpha-amidated peptides and glyoxylate. Its activity is essential for the maturation of numerous neural and endocrine peptides.
Therapeutic significance:
Understanding the role of Peptidyl-glycine alpha-amidating monooxygenase could open doors to potential therapeutic strategies. Its crucial function in peptide maturation highlights its potential as a target for developing treatments that modulate peptide-mediated biological processes.